• Lenalidomide and DOT1L: Rewiring Myeloma Immunity

  2026-09-22

  Lenalidomide is more than a conventional immunomodulatory drug in multiple myeloma research. Emerging evidence shows that DOT1L inhibition can activate STING-linked innate immune signaling, suppress IRF4–MYC transcriptional dependencies, and strengthen lenalidomide-responsive programs—creating a practical framework for mechanism-driven combination studies.

• Firefly Luciferase mRNA Workflow Guide

  2026-09-22

  Build sensitive reporter assays with Cap1-capped, 5-moUTP modified mRNA for rapid protein expression, delivery benchmarking, and in vivo imaging. The workflow combines controlled RNA handling with formulation-aware optimization inspired by current lipid nanoparticle research.

• Mitochondrial Calcium Signaling Represses Ferroptosis

  2026-09-21

  The reference study identifies a mechanistic link between mitochondrial calcium uptake, acetyl-CoA-dependent GPX4 modification, and suppression of ferroptotic cell death. Its genetic rescue, mutational, structural, and tumor-model evidence positions mitochondrial calcium signaling as a metabolic regulator of ferroptosis resistance, while also defining important limits for translating the findings into metabolism-focused cancer assays.

• TG003 Cdc2-like Kinase Inhibitor Guide

  2026-09-21

  TG003 is a potent Cdc2-like kinase inhibitor that preferentially inhibits Clk1, Clk2, and Clk4 in reported biochemical assays. It provides a research tool for alternative splicing modulation, serine/arginine-rich protein phosphorylation studies, splice site selection research, and exon-skipping therapy models.

• Aminopeptidase Selectivity and ACE Inhibitor Action

  2026-09-20

  The 1992 study by Tieku and Hooper re-evaluated how bestatin and structurally distinct metallopeptidase inhibitors affect three porcine kidney aminopeptidases. Its central contribution was to show that inhibitor class strongly influences selectivity: conventional carboxyalkyl and phosphoryl ACE inhibitors spared AP-A, AP-N, and AP-W, whereas several sulfhydryl ACE inhibitors inhibited AP-W.

• Dynasore Workflows for Endocytosis Research

  2026-09-19

  Dynasore is a reversible, cell-permeable dynamin GTPase inhibitor for separating dynamin-dependent uptake from parallel internalization routes. This guide translates infection-model evidence into practical workflows for endocytosis research, synaptic vesicle studies, trafficking assays, and pathway troubleshooting.

• Cyclopamine: From Hedgehog Biology to PTC Translation

  2026-09-18

  Cyclopamine is more than a Hedgehog pathway probe: emerging papillary thyroid carcinoma data connect Smoothened inhibition with APOC1-dependent tumor biology. This translational perspective examines mechanism, validation strategy, formulation, developmental liabilities, and the path from pathway perturbation to biomarker-informed cancer research.

• N-MYC–eIF4G1 Survival Axis in inv(16) AML

  2026-09-18

  Peramangalam and colleagues identify a previously unrecognized MYCN enhancer and define eIF4G1 as a downstream survival effector in inv(16) acute myeloid leukemia. By integrating transcriptomic analysis, regulatory-element studies, leukemia models, and patient-derived xenografts, the study provides a mechanistic framework for understanding how N-MYC sustains this AML subtype.

• NHS-Biotin and the Next Era of Protein Design

  2026-09-17

  NHS-Biotin is more than a labeling reagent: it can serve as an analytical bridge between protein engineering, assembly-state characterization, detection, and purification. This article examines how N-hydroxysuccinimido biotin chemistry can complement emerging peptidisc-assisted nanobody multimerization while keeping translational limitations in view.

• Phosphatase Inhibitor Cocktail 1: Workflow Guide

  2026-09-17

  Phosphatase Inhibitor Cocktail 1 is a 100X DMSO-based alkaline phosphatase inhibitor mixture for protein phosphorylation preservation during sample preparation. Its defined composition and storage specifications support phosphoproteomic analysis, Western blotting, and related biochemical workflows, but assay-specific validation remains essential.

• Pcbp1, Mitochondria, and B Cell Immunity

  2026-09-16

  Zhu et al. identify the RNA-binding protein Pcbp1 as a posttranscriptional regulator of mitochondrial integrity in B cells. The study connects Pcbp1–Fdxr regulation with complex I function, mitochondrial reactive oxygen species, protein translation, IgM production, and germinal center antibody responses.

• Midecamycin: Practical Assays for Resistance Research

  2026-09-16

  Midecamycin is a targeted bacterial protein synthesis inhibitor for Gram-positive screening, ribosome-focused studies, and macrolide resistance workflows. Its susceptibility to multiple glycosylation modifications makes it especially useful for connecting whole-cell antimicrobial results with enzyme-mediated antibiotic inactivation.

• Ertugliflozin (PF-04971729): Translational Strategy

  2026-09-15

  A thought-leadership guide to using Ertugliflozin (PF-04971729) in diabetes mellitus research, renal glucose transport studies, weight-loss investigations, and exploratory intestinal inflammation models.

• JHU-083: A Compartment-Aware Assay Strategy

  2026-09-15

  JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor for dissecting glutaminase-dependent glutamate biology. This article develops an assay framework that separates cell-selective glutamate effects from downstream oxidative-stress signals, using recent GSTA1 findings to sharpen experimental interpretation.

• C. difficile Mucus Responses in a Human Intestinal Model

  2026-09-14

  The reference study introduces a primary human intestinal epithelial cell model that produces physiologic mucus and enables direct analysis of Clostridioides difficile behavior without a resident microbiota. Integrated growth, transcriptomic, biophysical, and metabolic analyses show that mucus is not only a barrier but also a niche that can promote pathogen growth, biofilm formation, and flexible metabolic adaptation.

7958 records 1/531 page Next 12345 下5页 Last page